Humacyte director Keith Anthony Jones acquires 30,000 shares worth $17,820

• Humacyte director Keith Anthony Jones reported buying 30,000 common shares at a weighted average price of $0.59.
• His direct holdings rose to 30,000 shares following the purchase.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Humacyte Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-356847), on August 19, 2026, and is solely responsible for the information contained therein.